Biogen (BIIB) 10-K2005 FY Annual report

Filed: 3 Mar 06, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: abatacept, accomplish, acetaminophen, Albany, Alexander, Allegany, Ambrogne, Amsterdam, ANDA, andEITF, andRule, Anita, anti, argument, ASP, Bannester, basophil, Bayer, beneficiary, bifunctional, bioavailability, bioequivalence, BioPharma, black, Boston, Bowler, box, Broome, Cabot, calendar, carcinoma, Cayuga, Celltech, Chron, citizen, clarity, commonly, Commonwealth, comparison, compatible, constrain, copy, Cortland, crosslinking, cytokine, Czapla, daclizumab, decedent, defrauding, dialogue, disbursed, dispensed, divest, divestiture, driven, earliest, eighteen, ENCORE, encouraging, entrepreneurial, Eric, ESPP, Essex, evolving, exam, excusal, expedited, Faheem, FAS, fibrotic, FileNo, Fine, fontolizumab, formal, formally, formation, Fulton, GAP, Genesee, Greene, ground, Hamm, hardware, Hasnain, heard, Herkimer, Hinckley, Hoofddorp, husband, HuZAFtm, idiopathic, IgG, immunoregulatory, impracticable, ingredient, instance, internationally, internet, intervene, intolerant, IONA, IPO, irreversible, Jefferson, Jill, juridical, Justice, kind, Kowolenko, Lindsay, Lobel, Louisiana, Lymphome, lymphotoxin, Madison, Magistrate, Maine, Marianne, mast, McDermott, melanoma, MHC, Middlesex, misrepresentation, Monroe, morbidity, negligence, network, Niagara, NICO, NIMO, noncompliance, Northern, occupied, ofForm, ofIFN, Oneida, onForm, onpage, Ontario, ORENCIA, outlay, outplacement, overdraft, PANACLAR, pancreatic, Panel, PAREXEL, pathway, PDL, penalty, petition, petitioned, pioneer, plead, pleaded, pleading, predecessor, prematurely, prepaid, punitive, Putnam, QC, questionnaire, recalculate, recalibrating, reclassed, reconsideration, reconsidered, Redhibition, Reginald, remand, resignation, respiratory, retail, route, RTP, salary, Saratoga, Schuyler, seal, Senate, Seneca, seq, shaped, Snyder, software, spanning, Squibb, staffing, Steuben, Street, strict, strive, subpoena, substantive, summer, surrender, surrogate, Susan, Syntex, Tanox, thirty, thisForm, threshold, TriCARE, UCB, unavoidable, unilaterally, unissued, Unresolved, unsealed, version, volociximab, Walter, Warren, Washington, Wayne, Western, withholding, wrongful

Removed: arbitrage, arm, Asia, biology, bulky, called, capitalization, chemistry, commissioning, computation, contrast, decide, declaratory, directing, earlier, education, EITF, eliminate, emerging, escrow, existed, extend, faculty, forced, fulfill, function, IDPH, Illumina, improved, improving, incurring, integration, invalid, invested, Israel, leveraged, minimizing, Mitsubishi, modifying, multiplied, Nordion, overactive, pilot, population, post, prepared, promissory, qualitative, repeating, Seikagaku, semiannual, semiannually, short, Simultaneously, Stanford, successor, Taisho, Tokyo, unaudited, unenforceable, union, vulnerable, withdrawing, Wyoming

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

BIIB similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation by reference in the Registration Statement onForm S-3(No. 333-89792), Registration Statement onForm S-4 (No.333-107098) and Registration Statements onForm S-8 (Nos.333-97211,333-106794,333-65494,333-47904,333-81625,333-110432,333-110433 and333-128339) of Biogen Idec Inc. of our report dated March 2, 2006 relating to the financial statements, financial statement schedule, management’s assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting, which appears in thisForm 10-K.

/s/ PricewaterhouseCoopers

Boston, Massachusetts

March 3, 2006